DOCSLIB.ORG

GABA Uptake-Dependent Ca Signaling in Developing Olfactory Bulb

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

GABA uptake-dependent Ca2؉ signaling in developing olfactory bulb astrocytes Michael Doengia,b,c, Daniela Hirnetb,c, Philippe Coulonc, Hans-Christian Papec, Joachim W. Deitmera, and Christian Lohra,b,c,1 aAbteilung fu¨r Allgemeine Zoologie, Universita¨t Kaiserslautern, Postfach 3049, D-67653 Kaiserslautern, Germany; and bInterdisziplina¨res Zentrum fu¨r Klinische Forschung and cInstitut fu¨r Physiologie I, Westfa¨lische Wilhelms-Universita¨t Mu¨ nster, D-48149 Mu¨nster, Germany Edited by Tullio Pozzan, University of Padua, Padua, Italy, and approved August 21, 2009 (received for review November 25, 2008) We studied GABAergic signaling in astrocytes of olfactory bulb slices (11), raising the question how astrocytes are integrated in .using confocal Ca2؉ imaging and two-photon Na؉ imaging. GABA inhibitory neuronal networks evoked Ca2؉ transients in astrocytes that persisted in the presence of Besides GABA receptors, astrocytes express GABA transporters GABAA and GABAB receptor antagonists, but were suppressed by (GATs), which significantly contribute to the clearance of GABA inhibition of GABA uptake by SNAP 5114. Withdrawal of external molecules from the synaptic cleft (12), but have not yet been .Ca2؉ blocked GABA-induced Ca2؉ transients, and depletion of Ca2؉ considered to directly participate in neuronal signal processing ,stores with cyclopiazonic acid reduced Ca2؉ transients by approxi- Glial GATs are also involved in pathological processes in the brain -mately 90%. This indicates that the Ca2؉ transients depend on for example, in patients with temporal lobe epilepsy, where astro external Ca2؉, but are mainly mediated by intracellular Ca2؉ release, cytic expression of GATs is increased (13), and inhibitors of glial conforming with Ca2؉-induced Ca2؉ release. Inhibition of ryanodine GATs have anticonvulsant effects (14), indicating the involvement ,receptors did not affect GABA-induced Ca2؉ transients, whereas the of glial GATs in the generation of epileptic seizures. It is not known 2؉ InsP3 receptor blocker 2-APB inhibited the Ca transients. GABA also however, how glial GATs contribute to epileptic seizures. -induced Na؉ increases in astrocytes, potentially reducing Na؉/Ca2؉ In this study, we have investigated the role of GATs for neuron ,exchange. To test whether reduction of Na؉/Ca2؉ exchange induces glia signaling. We have chosen the olfactory bulb for this study Ca2؉ signaling, we inhibited Na؉/Ca2؉ exchange with KB-R7943, because astrocytic processes ensheath dendrodendritic, mostly NEUROSCIENCE which mimicked GABA-induced Ca2؉ transients. Endogenous GABA GABAergic synapses (15, 16). Our results indicate a principle of GABAergic signaling between neurons and glial cells mediated by release from neurons, activated by stimulation of afferent axons or ϩ 2؉ GATs. Activation of GABA uptake elicited an intracellular Na NMDA application, also triggered Ca transients in astrocytes. The ϩ significance of GABAergic Ca2؉ signaling in astrocytes for control of rise in olfactory bulb astrocytes. Our results suggest that this Na rise reduced Naϩ/Ca2ϩ exchange, thereby leading to a Ca2ϩ in- blood flow is demonstrated by SNAP 5114-sensitive constriction of crease sufficient to trigger Ca2ϩ-induced Ca2ϩ release via InsP blood vessels accompanying GABA uptake. The results suggest that 3 receptors. Thus, in addition to clearance of GABA from the GABAergic signaling is composed of GABA uptake-mediated Na؉ rises synaptic cleft, GABA uptake might serve as a mediator for neuron- that reduce Na؉/Ca2؉ exchange, thereby leading to a Ca2؉ increase .2؉ 2؉ glia signaling sufficient to trigger Ca -induced Ca release via InsP3 receptors. Hence, GABA transporters not only remove GABA from the extracel- Results lular space, but may also contribute to intracellular signaling and 2؉ GABAA Receptors Mediate Ca Signaling in Neurons But Not in astrocyte function, such as control of blood flow. Astrocytes. In brain slices of 2- to 7-day-old mice (P2–7), application of GABA (300 ␮M) evoked Ca2ϩ transients in 69% of olfactory ͉ ͉ calcium-induced calcium release GABA transporter bulb astrocytes (n ϭ 899 cells/39 slices/29 animals) and 75% of Neuron-glia interaction ͉ sodium imaging ͉ vasoconstriction periglomerular neurons (n ϭ 261/10/6), with mean amplitudes of 128.7 Ϯ 2.5% ⌬F(n ϭ 621/39/29) and 76.1 Ϯ 3.2% ⌬F(n ϭ lial cells are electrically inexcitable cells in the nervous 195/10/6), respectively (Fig. 1A). In 3-week-old animals (P18–22), Gsystem and have long been considered to be supporting cells the fraction of responsive cells decreased to 34% of astrocytes (n ϭ with little direct impact on neuronal performance. It was only in 47/8/4) and 29% of neurons (n ϭ 306/8/3), with amplitudes of 76.8 Ϯ the last decade when it was recognized that astrocytes, the major 14.5% ⌬F(n ϭ 16/8/4) and 81.7 Ϯ 5.4% ⌬F(n ϭ 88/8/3) (Fig. S1), ϩ class of glial cells in the mammalian brain, participate in synaptic indicating that GABAergic Ca2 signaling in astrocytes and neu- transmission and contribute to information processing. This led rons is developmentally regulated. to the model of the ‘‘tripartite synapse’’ consisting of pre- and We further studied the mechanism underlying GABA-induced ϩ postsynaptic neuronal elements and glial processes (1). Astro- Ca2 signaling using mice at an age of P2–7. In addition to ϩ ϩ cytes detect neuronal release of excitatory neurotransmitters GABA-evoked Ca2 signaling, spontaneous Ca2 transients or 2ϩ such as glutamate and acetylcholine via G protein-coupled Ca oscillations could also be measured in 68% of the astrocytes ϩ ϭ receptors and respond with cytosolic Ca2 signaling (2–4). (n 115/2/2; Fig. 1A, asterisks) and 25% of the periglomerular ϭ 2ϩ Astrocytes can then release ‘‘gliotransmitters’’ such as gluta- neurons (n 56/2/2). If spontaneous Ca signaling occurred mate, D-serine and arachidonic acid in a Ca2ϩ-dependent man- shortly before the application of GABA, cells were not used for ner, thus modulating neuronal performance and local cerebro- analysis. vascular blood flow (5–8). While most studies describe the integration of astrocytes in excitatory neuronal networks in great Author contributions: M.D., D.H., J.W.D., and C.L. designed research; M.D., D.H., and P.C. detail (reviewed in ref. 1), only little information exists about performed research; M.D., D.H., and C.L. analyzed data; and H.-C.P., J.W.D., and C.L. wrote how astrocytes are affected by inhibitory neurotransmitters such the paper. as GABA and glycine. GABAA and GABAB receptor-mediated The authors declare no conflict of interest. 2ϩ Ca signaling has been reported in hippocampal astrocytes This article is a PNAS Direct Submission. (9–11), where GABAB receptors mediate heterosynaptic de- 1To whom correspondence should be addressed. E-mail: [email protected]. pression (10). Only a minority of hippocampal astrocytes, how- This article contains supporting information online at www.pnas.org/cgi/content/full/ 2ϩ ever, respond to GABAB receptor activation with Ca increases 0809513106/DCSupplemental. www.pnas.org͞cgi͞doi͞10.1073͞pnas.0809513106 PNAS Early Edition ͉ 1of6 Downloaded by guest on September 29, 2021 Fig. 2. GABA uptake mediates Ca2ϩ signaling in olfactory bulb astrocytes. (A) The GABA transporter substrate nipecotic acid (NPA) induced Ca2ϩ transients similar to GABA-induced Ca2ϩ transients. The Ca2ϩ transients were not blocked by GABA receptor antagonists (60 ␮M gabazine, 10 ␮M CGP52432). NBQX (30 ␮M) Fig. 1. GABA-mediated Ca2ϩ signaling in olfactory bulb astrocytes. (A) The and D-AP5 (100 ␮M) were applied to suppress epileptiform activity induced by GABA receptor antagonist gabazine (60 ␮M) blocked Ca2ϩ transients induced by A gabazine. (B) Upper trace, the GAT inhibitor SNAP 5114 evoked Ca2ϩ oscillations GABA (300 ␮M) in neurons (lower trace), but not in astrocytes (upper trace) at in astrocytes, rendering analysis of putative GABA-induced Ca2ϩ transients in P2–7. Asterisks indicate spontaneous Ca2ϩ signaling. (B) Dose-response curve of single astrocytes difficult. Lower trace, averaged Ca2ϩ signal from 13 individual GABA-induced Ca2ϩ transients in neurons (open squares) and astrocytes (closed astrocytes of one experiment to reduce unsynchronized Ca2ϩ oscillations and squares). (C) The GABA receptor antagonist CGP52432 (10 ␮M) blocked Ca2ϩ B unmask GABA-evoked Ca2ϩ transients. Inhibiting GABA uptake with SNAP 5114 transients elicited by baclofen (Bac, 300 ␮M), but not Ca2ϩ transients elicited by (100 ␮M) suppressed GABA-induced Ca2ϩ signaling. GABA (300 ␮M). (D) TTX (2 ␮M) only weakly reduced GABA-induced Ca2ϩ tran- sients in astrocytes. (E) Agonist profile of Ca2ϩ signaling in astrocytes. (F) Antag- 2ϩ ␮ ␮ onist profile of GABA-induced Ca signaling. CGP52432 (10 M) and TTX (2 M) 2ϩ ϩ GABA-induced Ca signaling cannot be explained by GABA significantly reduced GABA-induced Ca2 transients in astrocytes. *,PϽ0.05; ***, B P Ͻ 0.005. Bars, means ϩ error of the mean; n, the number of cells investigated. receptor activation. The results show that GABA receptors mediate Ca2ϩ signaling only in a minority of olfactory bulb astrocytes. They also argue 2ϩ Blocking GABAA receptors with gabazine suppressed GABA- against the possibility that Ca transients in astrocytes depend on induced Ca2ϩ transients in periglomerular neurons (n ϭ 132/7/6; GABA-driven activity of neurons or any other neuronal activity, P Ͻ 0.005), but had no effect on the amplitude of Ca2ϩ transients since inhibiting action potential firing with TTX (2 ␮M) only 2ϩ in astrocytes (n ϭ 28/5/4; Fig. 1 A and F). The GABAA receptor marginally reduced GABA-induced Ca transient amplitudes in channel blocker picrotoxin (100 ␮M) reduced neuronal GABA- astrocytes by 9.5 Ϯ 4.5% (n ϭ 16/3/3; P ϭ 0.011; Fig. 1D), and 2ϩ evoked Ca2ϩ transient amplitudes to 34.2 Ϯ 4.1% (n ϭ 49/3/2; P Ͻ gabazine blocked Ca responses in periglomerular neurons, but 2ϩ 0.005), whereas astrocytic Ca2ϩ transients remained unaffected not in astrocytes.
Recommended publications
  • GABAA Transmission Is a Critical Step in the Process of Triggering Homeostatic Increases in Quantal Amplitude

    GABAA Transmission Is a Critical Step in the Process of Triggering Homeostatic Increases in Quantal Amplitude

    GABAA transmission is a critical step in the process of triggering homeostatic increases in quantal amplitude Jennifer C. Wilhelm and Peter Wenner* Department of Physiology, Emory University School of Medicine, Atlanta, GA 30322 Communicated by Lynn T. Landmesser, Case Western Reserve University, Cleveland, OH, June 23, 2008 (received for review March 1, 2008) When activity levels are altered over days, a network of cells is models suggests that reducing network activity produces a corre- capable of recognizing this perturbation and triggering several dis- sponding reduction in cellular spiking activity, thereby reducing tinct compensatory changes that should help to recover and maintain intracellular calcium levels in a postsynaptic cell. In this model, the original activity levels homeostatically. One feature commonly which we will refer to as the cell activity model, the postsynaptic cell observed after activity blockade has been a compensatory increase in senses changes in intracellular calcium levels as a measure of altered excitatory quantal amplitude. The sensing machinery that detects activity and triggers compensatory changes in mPSC amplitude. altered activity levels is a central focus of the field currently, but thus However, the studies that have inspired this model not only block far it has been elusive. The vast majority of studies that reduce spiking activity, they also block or reduce neurotransmitter binding network activity also reduce neurotransmission. We address the to its receptor and any associated downstream signaling cascades. possibility that reduced neurotransmission can trigger increases in Thus, it remains possible that neurotransmission is a critical step in quantal amplitude. In this work, we blocked glutamatergic or GABAA the sensing process that triggers changes in quantal amplitude.
  • Neurotransmitters-Drugs Andbrain Function.Pdf

    Neurotransmitters-Drugs Andbrain Function.Pdf

    Neurotransmitters, Drugs and Brain Function. Edited by Roy Webster Copyright & 2001 John Wiley & Sons Ltd ISBN: Hardback 0-471-97819-1 Paperback 0-471-98586-4 Electronic 0-470-84657-7 Neurotransmitters, Drugs and Brain Function Neurotransmitters, Drugs and Brain Function. Edited by Roy Webster Copyright & 2001 John Wiley & Sons Ltd ISBN: Hardback 0-471-97819-1 Paperback 0-471-98586-4 Electronic 0-470-84657-7 Neurotransmitters, Drugs and Brain Function Edited by R. A. Webster Department of Pharmacology, University College London, UK JOHN WILEY & SONS, LTD Chichester Á New York Á Weinheim Á Brisbane Á Singapore Á Toronto Neurotransmitters, Drugs and Brain Function. Edited by Roy Webster Copyright & 2001 John Wiley & Sons Ltd ISBN: Hardback 0-471-97819-1 Paperback 0-471-98586-4 Electronic 0-470-84657-7 Copyright # 2001 by John Wiley & Sons Ltd. Bans Lane, Chichester, West Sussex PO19 1UD, UK National 01243 779777 International ++44) 1243 779777 e-mail +for orders and customer service enquiries): [email protected] Visit our Home Page on: http://www.wiley.co.uk or http://www.wiley.com All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency Ltd, 90 Tottenham Court Road, London W1P0LP,UK, without the permission in writing of the publisher. Other Wiley Editorial Oces John Wiley & Sons, Inc., 605 Third Avenue, New York, NY 10158-0012, USA WILEY-VCH Verlag GmbH, Pappelallee 3, D-69469 Weinheim, Germany John Wiley & Sons Australia, Ltd.
  • Molecular Dissection of G-Protein Coupled Receptor Signaling and Oligomerization

    Molecular Dissection of G-Protein Coupled Receptor Signaling and Oligomerization

    MOLECULAR DISSECTION OF G-PROTEIN COUPLED RECEPTOR SIGNALING AND OLIGOMERIZATION BY MICHAEL RIZZO A Dissertation Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE SCHOOL OF ARTS AND SCIENCES in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY Biology December, 2019 Winston-Salem, North Carolina Approved By: Erik C. Johnson, Ph.D. Advisor Wayne E. Pratt, Ph.D. Chair Pat C. Lord, Ph.D. Gloria K. Muday, Ph.D. Ke Zhang, Ph.D. ACKNOWLEDGEMENTS I would first like to thank my advisor, Dr. Erik Johnson, for his support, expertise, and leadership during my time in his lab. Without him, the work herein would not be possible. I would also like to thank the members of my committee, Dr. Gloria Muday, Dr. Ke Zhang, Dr. Wayne Pratt, and Dr. Pat Lord, for their guidance and advice that helped improve the quality of the research presented here. I would also like to thank members of the Johnson lab, both past and present, for being valuable colleagues and friends. I would especially like to thank Dr. Jason Braco, Dr. Jon Fisher, Dr. Jake Saunders, and Becky Perry, all of whom spent a great deal of time offering me advice, proofreading grants and manuscripts, and overall supporting me through the ups and downs of the research process. Finally, I would like to thank my family, both for instilling in me a passion for knowledge and education, and for their continued support. In particular, I would like to thank my wife Emerald – I am forever indebted to you for your support throughout this process, and I will never forget the sacrifices you made to help me get to where I am today.
  • GABA Receptors

    GABA Receptors

    D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43.
  • Small Molecule Modulators Reveal Mechanisms Regulating Cell Death

    Small Molecule Modulators Reveal Mechanisms Regulating Cell Death

    Investigating neurodegenerative diseases with small molecule modulators Reka Rebecca Letso Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2011 ©2011 Reka Rebecca Letso All Rights Reserved Abstract Investigating neurodegenerative diseases with small molecule modulators Reka Rebecca Letso Elucidation of the mechanisms underlying cell death in neurodegenerative diseases has proven difficult, due to the complex and interconnected architecture of the nervous system as well as the often pleiotropic nature of these diseases. Cell culture models of neurodegenerative diseases, although seldom recapitulating all aspects of the disease phenotype, enable investigation of specific aspects of these disease states. Small molecule screening in these cell culture models is a powerful method for identifying novel small molecule modulators of these disease phenotypes. Mechanistic studies of these modulators can reveal vital insights into the cellular pathways altered in these disease states, identifying new mechanisms leading to cellular dysfunction, as well as novel therapeutic targets to combat these destructive diseases. Small molecule modulators of protein activity have proven invaluable in the study of protein function and regulation. While inhibitors of protein activity are relatively common, small molecules that can increase protein abundance are quite rare. Small molecule protein upregulators with targeted activities would be of great value in the study of the mechanisms underlying many loss of function diseases. We developed a high- throughput screening approach to identify small molecule upregulators of the Survival of Motor Neuron protein (SMN), whose decreased levels cause the neurodegenerative disease Spinal Muscular Atrophy (SMA). We screened 69,189 compounds for SMN upregulators and performed mechanistic studies on the most active compound, a bromobenzophenone analog designated cuspin-1.
  • Inhibitory Role for GABA in Autoimmune Inflammation

    Inhibitory Role for GABA in Autoimmune Inflammation

    Inhibitory role for GABA in autoimmune inflammation Roopa Bhata,1, Robert Axtella, Ananya Mitrab, Melissa Mirandaa, Christopher Locka, Richard W. Tsienb, and Lawrence Steinmana aDepartment of Neurology and Neurological Sciences and bDepartment of Molecular and Cellular Physiology, Beckman Center for Molecular Medicine, Stanford University, Stanford, CA 94305 Contributed by Richard W. Tsien, December 31, 2009 (sent for review November 30, 2009) GABA, the principal inhibitory neurotransmitter in the adult brain, serum (13). Because actions of exogenous GABA on inflammation has a parallel inhibitory role in the immune system. We demon- and of endogenous GABA on phasic synaptic inhibition both strate that immune cells synthesize GABA and have the machinery occur at millimolar concentrations (5, 8, 9), we hypothesized that for GABA catabolism. Antigen-presenting cells (APCs) express local mechanisms may also operate in the peripheral immune functional GABA receptors and respond electrophysiologically to system to enhance GABA levels near the inflammatory focus. We GABA. Thus, the immune system harbors all of the necessary first asked whether immune cells have synthetic machinery to constituents for GABA signaling, and GABA itself may function as produce GABA by Western blotting for GAD, the principal syn- a paracrine or autocrine factor. These observations led us to ask thetic enzyme. We found significant amounts of a 65-kDa subtype fl further whether manipulation of the GABA pathway in uences an of GAD (GAD-65) in dendritic cells (DCs) and lower levels in animal model of multiple sclerosis, experimental autoimmune macrophages (Fig. 1A). GAD-65 increased when these cells were encephalomyelitis (EAE). Increasing GABAergic activity amelio- stimulated (Fig.
  • Protein Kinase C Activates an H' (Equivalent) Conductance in The

    Protein Kinase C Activates an H' (Equivalent) Conductance in The

    Proc. Nati. Acad. Sci. USA Vol. 88, pp. 10816-10820, December 1991 Cell Biology Protein kinase C activates an H' (equivalent) conductance in the plasma membrane of human neutrophils (HI channels/pH regulation/leukocytes/H+-ATPase/bafllomycin) ARVIND NANDA AND SERGIO GRINSTEIN* Division of Cell Biology, Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada Communicated by Edward A. Adelberg, August 12, 1991 ABSTRACT The rate of metabolic acid generation by it can be calculated that pH1 would be expected to drop by neutrophils increases greatly when they are activated. Intra- over 5 units (to pH 1.6) if the metabolically generated H+ cellular acidification is prevented in part by Na+/H' ex- were to remain within the cell. However, cells stimulated in change, but a sizable component ofH+ extrusion persists in the the nominal absence of Na+ and HCO- maintain their pH1 nominal absence of Na' and HCO3 . In this report we deter- above 6.4, suggesting that alternative (Na+- and HCO3- mined the contribution to H+ extrusion of a putative HI independent) H+ extrusion mechanisms must exist in acti- conductive pathway and its mode ofactivation. In unstimulated vated neutrophils. Accordingly, accelerated extracellular cells, H+ conductance was found to be low and unaffected by acidification can be recorded under these conditions. depolarization. An experimental system was designed to min- The existence of H+-conducting channels has been docu- imize the metabolic acid generation and membrane potential mented in snail neurones (5) and axolotl oocytes (6). In these changes associated with neutrophil activation. By using this tissues, the channels are inactive at the resting plasma system, (3-phorbol esters were shown to increase the H+ membrane potential (Em) but open when the membrane (equivalent) permeability of the plasma membrane.
  • A 3-Fold Kernel Approach for Characterizing Late Onset Alzheimer’S Disease

    A 3-Fold Kernel Approach for Characterizing Late Onset Alzheimer’S Disease

    bioRxiv preprint doi: https://doi.org/10.1101/397760; this version posted August 22, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A 3-fold kernel approach for characterizing Late Onset Alzheimer’s Disease Margherita Squillarioa,*, Federico Tomasia, Veronica Tozzoa, Annalisa Barlaa and Daniela Ubertib “for the Alzheimer’s Disease Neuroimaging Initiative**” aDIBRIS, University of Genoa, Via Dodecaneso 35, I-16146 Genova, Italy. E-mail address: {squillario, federico.tomasi, veronica.tozzo}@dibris.unige.it, [email protected] bDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123, Brescia, Italy. E-mail address: [email protected] * Corresponding author and Lead Contact. Tel: +39-010-353-6707; Fax: +39-010-353- 6699. ** Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp- content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf 1 bioRxiv preprint doi: https://doi.org/10.1101/397760; this version posted August 22, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • Autophagy Flux in Critical Illness, a Translational Approach

    Autophagy Flux in Critical Illness, a Translational Approach

    www.nature.com/scientificreports OPEN Autophagy fux in critical illness, a translational approach Nicolas Tardif 1,2, Franck Polia2, Inga Tjäder1,2, Thomas Gustafsson3 & Olav Rooyackers1,2 Recent clinical trials suggest that early nutritional support might block the induction of autophagy in Received: 17 October 2018 critically ill patients leading to the development of organ failure. However, the regulation of autophagy, Accepted: 7 June 2019 especially by nutrients, in critical illness is largely unclear. The autophagy fux (AF) in relation to critical Published: xx xx xxxx illness and nutrition was investigated by using an in vitro model of human primary myotubes incubated with serum from critically ill patients (ICU). AF was calculated as the diference of p62 expression in the presence and absence of chloroquine (50 µM, 6 h), in primary myotubes incubated for 24 h with serum from healthy volunteers (n = 10) and ICU patients (n = 93). We observed 3 diferent phenotypes in AF, non-altered (ICU non-responder group), increased (ICU inducer group) or blocked (ICU blocker group). This block was not associate with a change in amino acids serum levels and was located at the accumulation of autophagosomes. The increase in the AF was associated with lower serum levels of non-essential amino acids. Thus, early nutrition during critical illness might not block autophagy but could attenuate the benefcial efect of starvation on reactivation of the autophagy process. This could be of clinical importance in the individual patients in whom this process is inhibited by the critical illness insult. Critically ill patients treated in an Intensive Care Unit (ICU) ofen have organ failure already at their admittance or will develop it early during their stay in the unit.
  • GABA Receptor Crosstalk the Inhibitory Neurotransmitter GABA Activates Both Ionotropic

    GABA Receptor Crosstalk the Inhibitory Neurotransmitter GABA Activates Both Ionotropic

    RESEARCH HIGHLIGHTS IN BRIEF SYNAPTIC TRANSMISSION GABA receptor crosstalk The inhibitory neurotransmitter GABA activates both ionotropic type A GABA receptors (GABAARs) and metabotropic GABAB receptors (GABABRs). Two independent studies in rat brain slices now show that activation of postsynaptic GABABRs enhances signalling through extrasynaptic GABAARs. Activity-dependent changes in GABA concentration activate postsynaptic GABABRs leading to slow inhibition, whereas high-affinity GABAARs at extrasynaptic sites are activated tonically by ambient GABA. This tonic inhibitory tone has been implicated in synaptic integration, anxiety-related behaviours and seizure susceptibility. Tao et al. show that activation of postsynaptic GABABRs enhances GABAAR-mediated currents caused by exogenous GABA or the GABABR agonist baclofen in dentate gyrus granule cells (DGGCs) but not in CA1 pyramidal neurons or cortical layer 2/3 pyramidal neurons. Connelly et al. report similar crosstalk in thalamocortical neurons of the ventrobasal thalamus and cerebellar granule cells as well as in DGGCs. ORIGINAL RESEARCH PAPERS Tao, W. et al. Postsynaptic GABAB receptors enhance extrasynaptic GABAA receptor function in dentate gyrus granule cells. J. Neurosci. 33, 3738–3743 (2013) | Connelly, W. M. et al. GABAB receptors regulate extrasynaptic GABAA receptors. J. Neurosci. 33, 3780–3785 (2013) SIGNAL TRANSDUCTION JACOB reveals the origin of NMDAR signals Signalling through NMDA receptors (NMDARs) can trigger cell death or survival depending on whether activation of such receptors occurs at extrasynaptic or synaptic sites, respectively. It is unclear how these opposing signals are communicated to and discriminated by the nucleus, but the authors of this study show that differential phosphorylation of JACOB relays the origin of the NMDAR signal to the nucleus.
  • Gabaergic Signaling Linked to Autophagy Enhances Host Protection Against Intracellular Bacterial Infections

    Gabaergic Signaling Linked to Autophagy Enhances Host Protection Against Intracellular Bacterial Infections

    ARTICLE DOI: 10.1038/s41467-018-06487-5 OPEN GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections Jin Kyung Kim1,2,3, Yi Sak Kim1,2,3, Hye-Mi Lee1,3, Hyo Sun Jin4, Chiranjivi Neupane 2,5, Sup Kim1,2,3, Sang-Hee Lee6, Jung-Joon Min7, Miwa Sasai8, Jae-Ho Jeong 9,10, Seong-Kyu Choe11, Jin-Man Kim12, Masahiro Yamamoto8, Hyon E. Choy 9,10, Jin Bong Park 2,5 & Eun-Kyeong Jo1,2,3 1234567890():,; Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the brain; however, the roles of GABA in antimicrobial host defenses are largely unknown. Here we demonstrate that GABAergic activation enhances antimicrobial responses against intracel- lular bacterial infection. Intracellular bacterial infection decreases GABA levels in vitro in macrophages and in vivo in sera. Treatment of macrophages with GABA or GABAergic drugs promotes autophagy activation, enhances phagosomal maturation and antimicrobial responses against mycobacterial infection. In macrophages, the GABAergic defense is mediated via macrophage type A GABA receptor (GABAAR), intracellular calcium release, and the GABA type A receptor-associated protein-like 1 (GABARAPL1; an Atg8 homolog). Finally, GABAergic inhibition increases bacterial loads in mice and zebrafish in vivo, sug- gesting that the GABAergic defense plays an essential function in metazoan host defenses. Our study identified a previously unappreciated role for GABAergic signaling in linking antibacterial autophagy to enhance host innate defense against intracellular bacterial infection. 1 Department of Microbiology, Chungnam National University School of Medicine, Daejeon 35015, Korea. 2 Department of Medical Science, Chungnam National University School of Medicine, Daejeon 35015, Korea.
  • Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor

    Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor

    The Journal of Neuroscience, January 15, 1997, 17(2):625–634 Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor Shinya Ueno,1 John Bracamontes,1 Chuck Zorumski,2 David S. Weiss,3 and Joe Henry Steinbach1 Departments of 1Anesthesiology and 2Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, and 3University of Alabama at Birmingham, Neurobiology Research Center and Department of Physiology and Biophysics, Birmingham, Alabama 35294-0021 Anesthetic drugs are known to interact with GABAA receptors, bicuculline only partially blocked responses to pentobarbital. both to potentiate the effects of low concentrations of GABA and These observations indicate that the blockers do not compete to directly gate open the ion channel in the absence of GABA; with alphaxalone or pentobarbital for a single class of sites on the however, the site(s) involved in direct gating by these drugs is not GABAA receptor. Finally, at receptors containing a1b2(Y157S)g2L known. We have studied the ability of alphaxalone (an anesthetic subunits, both bicuculline and gabazine showed weak agonist steroid) and pentobarbital (an anesthetic barbiturate) to directly activity and actually potentiated responses to alphaxalone. These activate recombinant GABAA receptors containing the a1, b2, and observations indicate that the blocking drugs can produce allo- g2L subunits. Steroid gating was not affected when either of two steric changes in GABAA receptors, at least those containing this mutated b2 subunits [b2(Y157S) and b2(Y205S)] are incorporated mutated b2 subunit. We conclude that the sites for binding ste- into the receptors, although these subunits greatly reduce the roids and barbiturates do not overlap with the GABA-binding site.